Glycated hemoglobin and risk of stroke, ischemic and hemorrhagic, in Japanese men and women

Cerebrovascular Diseases

Volumn 26, Issue 3, 2008, Pages 310-316

  Sunaga, Kyoko ^a   Miura, Katsuyuki ^a,b   Naruse, Yuchi ^c   Sakurai, Masaru ^a   Morikawa, Yuko ^a   Kurosawa, Yutaka ^d   Nakagawa, Hideaki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d Toyama Public Health Center   (Japan)

Author keywords

Cohort studies; Diabetes; Glycated hemoglobin; Stroke

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC STROKE; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; STROKE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 48049102341     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149579     Document Type: Article

References (26)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-2038.
2. Barrett-Connor E, Khaw KT: Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988;128:116-123.
3. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E: Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke 1996;27:210-215.
4. Adlerberth AM, Rosengren A, Wilhelmsen L: Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men; a general population study. Diabetes Care 1998;21:539-545.
5. Hart CL, Hole DJ, Smith GD: Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland. Stroke 2000;31:1893-1896.
6. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
7. Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K: Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program. Stroke 1994;25:951-957.
8. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.
9. Asia Pacific Cohort Studies Collaboration: Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 2004;27:2836-2842.
10. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, Heiss G: Atherosclerosis Risk in Communities (ARIC) Study Investigators: Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care 1999;22:1077-1083.
11. Haheim LL, Holme I, Hjermann I, Leren P: Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects: 18-year follow-up of the Oslo Study. Stroke 1995;26:774-777.
12. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J 1983;287:867-870.
13. Hart CL, Hole DJ, Smith GD: Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley Study in Scotland. Stroke 1999;30:1999-2007.
14. Tanne D, Koren-Morag N, Goldbourt U: Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke 2004;35:2351-2355.
15. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB: Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-1773.
16. Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341-346.
17. Svendsen PA, Lauritzen T, Soegaard U, Nerup J: Glycosylated hemoglobin and steady-state mean blood glucose concentration in type I (insulin-dependent) diabetes. Diabetologia 1982;23:403-405.
18. 1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol 2005;4:821-826.
19. Myint PK, Sinha S, Wareham NJ, Bingham SA, Luben RN, Welch AA, Khaw KT: Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship? Stroke 2007;38:271-275.
20. Lawlor DA, Fraser A, Ebrahim S, Smith GD: Independent association of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women. PLoS Med 2007;4:e263-e267.
21. 1c (in Japanese). J Jpn Diabet Soc 2003;46:961-965.
22. Guidelines Sub-Committee: 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-183.
23. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW: Glycemic control and coronary heart disease risk in persons with and without diabetes: the Atherosclerosis Risk in Communities Study. Arch Intern Med 2005;165:1910-1916.
24. 1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004;141:413-420.
25. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K: Diabetes and the risk of stroke: the Honolulu Heart Program. JAMA 1987;257:949-952.
26. 1c measurement. Diabetes Care 2007;30:2399-2400.